
CAS 226929-39-1
:LB42708
Description:
LB42708, with the CAS number 226929-39-1, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular formula, structure, and physical properties may vary, compounds like LB42708 are typically evaluated for their biological activity, solubility, stability, and toxicity profiles. It is important to note that compounds in this category are often investigated for their interactions with biological targets, which can include enzymes or receptors, and may exhibit specific pharmacological effects. The development and characterization of such compounds involve rigorous testing and validation to ensure efficacy and safety for potential use in clinical settings. For detailed information regarding its specific characteristics, including its synthesis, mechanism of action, and any clinical data, consulting scientific literature or databases dedicated to chemical substances would be essential.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
4-[[1-[[1-[(4-Bromophenyl)methyl]-1H-imidazol-5-yl]methyl]-4-(1-naphthalenyl)-1H-pyrrol-3-yl]carbonyl]morpholine
CAS:Formula:C30H27BrN4O2Purity:97%Color and Shape:SolidMolecular weight:555.4650LB 42708
CAS:Controlled Product<p>Applications LB 42708 is a selective nonpeptidic Farnesyltransferase (FTase) inhibitor.LB42708 suppresses tumor growth and tumor angiogenesis in both xenograft tumor models of Ras-mutated HCT116 cells and its wild-type Caco-2 cells, indicating its potential application in the treatment of both Ras-mutated and wild type tumors.<br>References Kim, C., et. al.: Mol. Pharmacol., 78, 142 (2010)<br></p>Formula:C30H27BrN4O2Color and Shape:NeatMolecular weight:555.46LB42708
CAS:LB42708 is an orally active farnesyltransferase (FTase) inhibitor (IC50: 0.8/1.2/2.0 nM toward H/N/K-ras).Formula:C30H27BrN4O2Purity:99.36%Color and Shape:SolidMolecular weight:555.47



